SEOUL, South Korea

韩国首尔

,

，

Aug. 25, 2026

2026年8月25日

/PRNewswire/ -- Leading experts from around the globe are convening to examine what new scientific discoveries could mean for the millions of people living with movement disorders.

/美通社/ -- 全球顶尖专家齐聚一堂，探讨最新科学发现对数百万运动障碍患者可能带来的意义。

The

这

International Congress of Parkinson's Disease and Movement Disorders

国际帕金森病与运动障碍大会

®

®

in Seoul, Korea, October 4-8, will bring together more than 4,000 global leaders in the field to explore the complex relationship between aging and neurodegeneration, including the effects of frailty and comorbidities, cellular senescence, genetics, biomarkers, emerging therapies, and advances in brain stimulation and other technologies..

将于10月4日至8日在韩国首尔举行，汇聚全球4,000多位该领域的领袖人物，共同探讨衰老与神经退行性变之间的复杂关系，涵盖衰弱与共病的影响、细胞衰老、遗传学、生物标志物、新兴疗法，以及脑刺激和其他技术的最新进展。

'Age is one of the most important factors shaping the way movement disorders develop and affect patients, yet we are only beginning to understand the biological and clinical complexity that comes with aging,' said David Burn, FMedSci, MD, FRCP, President of the International Parkinson and Movement Disorder Society.

“年龄是塑造运动障碍疾病发生发展及其对患者影响的最重要因素之一，然而我们才刚刚开始理解与衰老相关的生物学和临床复杂性。”国际帕金森病和运动障碍学会主席、医学博士、皇家内科医师学会会员、医学科学院院士戴维·伯恩表示。

'The discoveries and discussions at the 2026 International Congress have the potential to change how we think about movement disorders across the lifespan.'.

“2026年国际大会上的发现与讨论，有望改变我们对全生命周期运动障碍的认知。”

2026 International Congress highlights include:

2026年国际大会亮点包括：

A keynote exploring the biology of aging and new therapeutic possibilities. Tohru Minamino, MD, PhD, of Japan, will deliver the MDS Keynote Lecture on immuno-gerotherapeutics targeting senescent cells for age-associated diseases, examining emerging strategies aimed at cellular processes associated with aging and neurodegeneration..

一场探讨衰老生物学及新治疗可能性的主旨演讲。来自日本的医学博士、哲学博士Tohru Minamino将发表MDS主旨演讲，主题为针对衰老细胞以治疗年龄相关疾病的免疫老年疗法，审视旨在应对与衰老和神经退行性变相关的细胞过程的新兴策略。

More than 60 timely

60多个及时

scientific sessions

科学会议

, covering emerging discoveries from genetics and neurobiology to new treatments, technologies, and controversial questions.

，涵盖从遗传学和神经生物学的新发现到新的治疗方法、技术以及争议性问题。

The newest research from around the world, including more than 2,000 novel abstracts, late-breaking studies, and clinical breakthroughs selected for their potential importance to the field and the public.

来自全球的最新研究成果，包括2000多篇新颖摘要、最新突破性研究以及因其对领域和公众具有潜在重要性而精选的临床突破。

More than 100 MDS groups will also meet to advance key society projects and research.

此外，100多个MDS小组将召开会议，以推进学会的重点项目和研究工作。

Members of the media can

媒体成员可以

apply for complimentary press registration

申请免费媒体注册

to the in-person event.

参加线下活动。

A

A

bout the 2026 MDS International Congress of Parkinson's Disease and Movement Disorders

关于2026年国际帕金森病和运动障碍大会（MDS）

®

®

:

：

The

这

MDS

MDS

International Congress is the premier annual event to advance the clinical and scientific discipline of Movement Disorders, including Parkinson's disease. Convening thousands of leading clinicians, scientists and other health professionals from around the globe, the International Congress will introduce more than 2,000 scientific abstracts and provide a forum for education and collaboration on latest research and treatment findings..

国际大会是推动运动障碍（包括帕金森病）临床与科学学科发展的顶级年度盛会。大会汇聚来自全球的数千名顶尖临床医生、科学家及其他医疗卫生专业人士，将展示2,000多篇科学摘要，并为围绕最新研究成果和治疗进展的教育与协作提供平台。

About the International Parkinson and Movement Disorder Society:

关于国际帕金森病与运动障碍学会：

The International Parkinson and Movement Disorder Society

国际帕金森病与运动障碍学会

®

®

(MDS), an international society of more than 12,000 clinicians, scientists, and other healthcare professionals, is dedicated to improving patient care through education and research. For more information about MDS, visit

（MDS）是一个拥有超过12,000名临床医生、科学家和其他医疗保健专业人员的国际性学会，致力于通过教育和研究改善患者护理。欲了解更多关于MDS的信息，请访问

www.movementdisorders.org

www.movementdisorders.org

.

。

SOURCE International Parkinson and Movement Disorder Society

来源：国际帕金森病与运动障碍学会

21

二十一

%

百分比

more press release views with

更多新闻稿浏览量与

Request a Demo

申请演示